The high price of agents GLP-1 is a non-favorable benefit scale
(MedPage Today)-Despite the great health benefits, the GLP-1 receptors were not effective costs at their current prices, according to the economic evaluation that compared four anti-metaphysical drugs. The net prices of Terzopatid (Montaru …